Effect of drug-test interactions on length of hospital stay

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 1, 2007, Pages 39-45

  Terleira, Ana ^a   Portolés, Antonio ^a   Rojas, Aurora ^a   Vargas, Emilio ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Drug test interaction; Hospital stay; Interactions

Indexed keywords

DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG INTERACTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTERNAL MEDICINE; LABORATORY TEST; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT INFORMATION; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DRUG INTERACTIONS; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LENGTH OF STAY; LINEAR MODELS; MALE; MEDICAL RECORDS DEPARTMENT, HOSPITAL; MODELS, STATISTICAL; PATIENT DISCHARGE;

EID: 33846468342     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1330     Document Type: Article

References (17)

1. Manase HR. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 1989; 46: 929-944.
2. Manase HR. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm 1989; 46: 1141-1152.
3. Van den Vemt Egberts TCC, Jong-van den Berg LTW, Brouwers RBJ. Drug-related problems in Hospitalised patients. Drug Safety 2000; 22(4): 321-333.
4. Smith JW, Seild LG, Leighton CE. Studies on the Epidemiology of Adverse Drug Reactions. V. Clinical Factors Influencing Susceptibility. Ann Inter Med 1968; 65: 629-640.
5. Seild LG, Thornton GF, Smith JW, Cluff LE. Studies on the epidemiology of adverse drug reactions. III. Reactions in patients on a general medical service. Bull Johns Hosk Hosp 1966; 119: 299-315.
6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200-1205.
7. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155: 1949-1956.
8. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke LP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-306.
9. Vargas E, Navarro MI, Laredo L, Garcia-Arenillas M, Garcia-Mateos M, Moreno A. Effect of drug interactions on the development of adverse drug reactions. Clin Drug invest 1997; 13(5): 282-289.
10. White TJ, Arakelian A, Rho JP. Counting the costs of drug-related adverse events. PharmacoEconomics 1999; 15: 445-458.
11. Jankel CA, Speedie SM. Detecting drug interactions: A review of the literature. DICP Ann Pharmacther 1990; 24: 982-989.
12. Ford DR, Rivers NP, Wood CG. A computerized detection system for potentially significant. J Am Pharm Assoc 1977; 17: 354-357.
13. Triquell R, Eguileor B, Mas R, de la Concepción M, Alemany P, Lizándara A. y col. Interacciones medicamento-medicamento. Farm Clin 1991; 5: 457-461.
14. Haumschild MJ, Ward ES, Bishop JM, Haumschild MS. Pharmacy-based computer system for monitoring and reporting drug interactions. Am J Hosp Pharm 1987; 44: 345-348.
15. Caraway WT. Chemical and diagnostic specificity of laboratory tests. Am J Clin Phatol 1962; 37: 445-464.
16. Salway JG. Drug-Test Interactions Handbook. Chapman and Hall: Cambridge, 1990.
17. Young DS. Effects of Drugs on Clinical Laboratory Test (3rd edn). AACC PRES: Washington, 1990.